IP Verse

Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring

PatentPatent Analysis

EP2545939

BIOMARIN PHARMACEUTICAL
Application Number
EP12005352A
Filing Date
Apr 11, 2008
Status
Revoked
Jul 7, 2023
Grant Date
Dec 16, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3328416B1
EP3461503B9
EP3138566B1

Bibliography

The patent EP2545939B1 was granted to Biomarin Pharmaceutical on Dec 16, 2020 following the initial filing on Apr 11, 2008 under the application number EP12005352A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CORIPHARMA EHFSep 16, 2021ADMISSIBLE
BETAPHARM ARZNEIMITTELSep 15, 2021ADMISSIBLE
STADA ARZNEIMITTELSep 14, 2021ADMISSIBLE
TEVA PHARMACEUTICALSSep 14, 2021WITHDRAWN
DIPHARMAJul 13, 2021WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents